Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma
- 1 November 2004
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 88 (1) , 75-85
- https://doi.org/10.1007/s10549-004-1200-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Matrix Metalloproteinase-2 (MMP-2) in T1–2N0 breast carcinomaBreast Cancer Research and Treatment, 2003
- Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neckCancer, 2002
- Expression of proteinases and inhibitors in human breast cancer progression and survivalMolecular Pathology, 2002
- Matrix metalloproteinases, their tissue inhibitors and colorectal cancer stagingBritish Journal of Surgery, 2000
- Different expression patterns of MMP-2 and MMP-9 in breast cancer.Oncology Reports, 1998
- Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review).International Journal of Oncology, 1998
- The Biochemistry of MetastasisPublished by Elsevier ,1996
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Prognostic factors in breast cancerSeminars in Surgical Oncology, 1989
- Do proteases play a role in cancer invasion and metastasis?European Journal of Cancer and Clinical Oncology, 1987